AMANDA BOLTON: Open Payments
NPI 1023545019 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,177 in 154 payments from 42 companies in 2025. Trend: 2023 $2,436 · 2024 $3,567 · 2025 $3,177
Food & beverage: $3,177
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $288 |
| Daiichi Sankyo Inc. | 11 | $237 |
| Novartis Pharmaceuticals Corporation | 11 | $210 |
| Merck Sharp & Dohme LLC | 8 | $193 |
| Janssen Biotech, Inc. | 9 | $180 |
| Aimmune Therapeutics, Inc. | 3 | $166 |
| PFIZER INC. | 9 | $156 |
| Incyte Corporation | 9 | $152 |
| Genentech USA, Inc. | 6 | $113 |
| Celgene Corporation | 6 | $99 |
Products named: ZENPEP, REBLOZYL, Enhertu, Fabhalta, KEYTRUDA, JAKAFI, IMFINZI, DATROWAY.
Industry payments across LA — which companies pay providers there.
